SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-025340
Filing Date
2024-02-06
Accepted
2024-02-06 16:47:30
Documents
18
Period of Report
2024-02-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d17634d8k.htm   iXBRL 8-K 26137
2 EX-99.1 d17634dex991.htm EX-99.1 191651
3 EX-99.2 d17634dex992.htm EX-99.2 50547
7 GRAPHIC g17634dsp005.jpg GRAPHIC 7153
8 GRAPHIC g17634dsp032.jpg GRAPHIC 9266
  Complete submission text file 0001193125-24-025340.txt   467401

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA advm-20240206.xsd EX-101.SCH 2849
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE advm-20240206_lab.xml EX-101.LAB 17234
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE advm-20240206_pre.xml EX-101.PRE 10811
20 EXTRACTED XBRL INSTANCE DOCUMENT d17634d8k_htm.xml XML 3516
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 24600911
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)